Neuroepidemiology Overview

Principles

Definition

Neuroepidemiology is the specialized field of epidemiology dedicated to studying the distribution, determinants, and frequency of neurological diseases and conditions within human populations. This discipline employs clinical and population-based research methods to identify risk factors, analyze trends in incidence and prevalence, and generate evidence essential for understanding disease etiology, informing prevention strategies, and guiding public health interventions.

Ontological type

Core Research Methods

Key Risk Factors

Major Disease Focus

Key developments

Key Figures

Clinicopathologic Foundations era

Wilder Penfield, a pioneering neurosurgeon, exemplifies the clinicopathologic integration by linking seizure semiology to cortical substrates through intraoperative stimulation and corroborating findings with autopsy. Kinnier Wilson's neuropathology work connected movement disorders to brain pathology through autopsy studies, illustrating how clinicopathologic correlation informed disease concepts. William G. Lennox contributed to mid-20th-century neuroepidemiology by assembling family-based series and refining epilepsy syndromes through electrophysiology and clinical observation. Together these figures show how the era used clinic-led diagnostic frameworks, autopsy-derived substrates, and ultrastructural and electrophysiological evidence to establish etiologic reasoning and shape neurosurgical and neuropsychological practice.

Population-Based Standardization era

Jeffrey L. Cummings [1], a prominent figure in neuroepidemiology during the Population-Based Standardization era, was affiliated with Harvard University [3] and the University of California, San Francisco [4]. His key contribution in this era stems from the 1993 paper Vascular dementia [6], which helped delineate the epidemiology and clinical significance of vascular factors in dementia, underscoring the population-based approach to tracking incidence and prognosis. Charles DeCarli [2], associated with the University of California, San Francisco [4] and Northwestern University [5], typifies this era's shift toward harmonized cohorts and standardized measures. His work on the same 1993 paper Vascular dementia [6] helped integrate noninvasive biomarkers and cross-study comparability into population-based neuroepidemiology, enabling broader longitudinal analyses.

Global Taxonomy and Surveillance era

Massimo Filippi [1] is associated with the University Memory and Aging Center [3] and the University of California, San Francisco [4] in the Global Taxonomy and Surveillance era. This contribution from Massimo Filippi [1] on the Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria [6] helped standardize MS diagnosis and enable harmonized case ascertainment across regions. Ludwig Kappos [2] is associated with Harvard University [5] and the University of California, San Francisco [4] during this era. Kappos [2]'s work on the 2010 McDonald criteria [6] contributed to unified MS diagnostic standards and facilitated cross-country burden estimates and policy-relevant planning, aligning with the era's surveillance aims.